Table of Content

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights


2. Assumptions and Research Methodology

2.1. Assumptions

2.2. Research Methodology


3. Executive Summary

3.1. Global Retinal Disorder Treatment Market Snapshot


4. Market Overview

4.1. Product Overview

4.2. Key Industry Events

4.3. Market Dynamics

4.3.1. Drivers and Restraints Snapshot Analysis

4.3.2. Drivers

4.3.3. Restraints

4.3.4. Opportunities

4.4. Global Retinal Disorder Treatment Market Revenue Projection

4.5. Global Retinal Disorder Treatment Market Outlook


5. Market Outlook

5.1. Clinical Trial Analysis

5.2. Regulatory Scenario

5.3. Pipeline Analysis

5.4. Key Mergers & Acquisitions

5.5. Reimbursement Scenario


6. Global Retinal Disorder Treatment Market Analysis, by Disease Indication

6.1. Introduction

6.2. Global Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication

6.3. Global Retinal Disorder Treatment Market Forecast, by Disease Indication

6.3.1. Macular Degeneration

6.3.1.1. Dry Macular Degeneration

6.3.1.2. Wet Macular Degeneration

6.3.2. Diabetic Retinopathy

6.3.3. Diabetic Macular Edema

6.3.4. Others (Retinal Vein Occlusion, etc.)


7. Global Retinal Disorder Treatment Market Analysis, by Therapeutic Class

7.1. Introduction

7.2. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class

7.3. North America Retinal Disorder Treatment Market Forecast, by Therapeutic Class

7.3.1. Anti-VEGF Agents

7.3.2. Others (Anti-inflammatory Drugs, etc.)


8. Global Retinal Disorder Treatment Market Analysis, by Dosage Form

8.1. Introduction

8.2. Global Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form

8.3. Global Retinal Disorder Treatment Market Forecast, by Dosage Form

8.3.1. Gels

8.3.2. Eye Solutions

8.3.3. Capsules & Tablets

8.3.4. Eye Drops

8.3.5. Ointments

8.4. Global Retinal Disorder Treatment Market Analysis, by Dosage Form


9. Global Retinal Disorder Treatment Market Analysis, by Distribution Channel

9.1. Introduction

9.2. Global Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

9.3. Global Retinal Disorder Treatment Market Forecast, by Distribution Channel

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Sales

9.4. Global Retinal Disorder Treatment Market Analysis, by Distribution Channel


10. Global Retinal Disorder Treatment Market Analysis, by Region

10.1. Global Retinal Disorder Treatment Market Scenario, by Country

10.2. Global Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Region

10.3. Global Retinal Disorder Treatment Market Forecast, by Region

10.3.1. North America

10.3.2. Europe

10.3.3. Asia Pacific

10.3.4. Latin America

10.3.5. Middle East & Africa


11. North America Retinal Disorder Treatment Market Analysis

11.1. Key Findings

11.2. North America Retinal Disorder Treatment Market Overview

11.3. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country

11.4. North America Retinal Disorder Treatment Market Forecast, by Country

11.4.1. U.S.

11.4.2. Canada

11.5. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication

11.6. North America Retinal Disorder Treatment Market Forecast, by Disease Indication

11.6.1. Macular Degeneration

11.6.1.1. Dry Macular Degeneration

11.6.1.2. Wet Macular Degeneration

11.6.2. Diabetic Retinopathy

11.6.3. Diabetic Macular Edema

11.6.4. Others (Retinal Vein Occlusion, etc.)

11.7. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class

11.8. North America Retinal Disorder Treatment Market Forecast, by Therapeutic Class

11.8.1. Anti-VEGF Agents

11.8.2. Others (Anti-inflammatory Drugs, etc.)

11.9. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form

11.10. North America Retinal Disorder Treatment Market Forecast, by Dosage Form

11.10.1. Gels

11.10.2. Eye Solutions

11.10.3. Capsules & Tablets

11.10.4. Eye Drops

11.10.5. Ointments

11.11. North America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

11.12. North America Retinal Disorder Treatment Market Forecast, by Distribution Channel

11.12.1. Hospital Pharmacies

11.12.2. Retail Pharmacies

11.12.3. Online Sales


12. Europe Retinal Disorder Treatment Market Analysis

12.1. Key Findings

12.2. Europe Retinal Disorder Treatment Market Overview

12.3. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

12.4. Europe Retinal Disorder Treatment Market Forecast, by Country/Sub-region

12.4.1. Germany

12.4.2. France

12.4.3. U.K.

12.4.4. Italy

12.4.5. Spain

12.4.6. Rest of Europe

12.5. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication

12.6. Europe Retinal Disorder Treatment Market Forecast, by Disease Indication

12.6.1. Macular Degeneration

12.6.1.1. Dry Macular Degeneration

12.6.1.2. Wet Macular Degeneration

12.6.2. Diabetic Retinopathy

12.6.3. Diabetic Macular Edema

12.6.4. Others (Retinal Vein Occlusion, etc.)

12.7. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class

12.8. Europe Retinal Disorder Treatment Market Forecast, by Therapeutic Class

12.8.1. Anti-VEGF Agents

12.8.2. Others (Anti-inflammatory Drugs, etc.)

12.9. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form

12.10. Europe Retinal Disorder Treatment Market Forecast, by Dosage Form

12.10.1. Gels

12.10.2. Eye Solutions

12.10.3. Capsules & Tablets

12.10.4. Eye Drops

12.10.5. Ointments

12.11. Europe Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

12.12. Europe Retinal Disorder Treatment Market Forecast, by Distribution Channel

12.12.1. Hospital Pharmacies

12.12.2. Retail Pharmacies

12.12.3. Online Sales

13. Asia Pacific Retinal Disorder Treatment Market Analysis

13.1. Key Findings

13.2. Asia Pacific Retinal Disorder Treatment Market Overview

13.3. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

13.4. Asia Pacific Retinal Disorder Treatment Market Forecast, by Country/Sub-region

13.4.1. Japan

13.4.2. China

13.4.3. India

13.4.4. Australia & New Zealand

13.4.5. Rest of Asia Pacific

13.5. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication

13.6. Asia Pacific Retinal Disorder Treatment Market Forecast, by Disease Indication

13.6.1. Macular Degeneration

13.6.1.1. Dry Macular Degeneration

13.6.1.2. Wet Macular Degeneration

13.6.2. Diabetic Retinopathy

13.6.3. Diabetic Macular Edema

13.6.4. Others (Retinal Vein Occlusion, etc.)

13.7. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class

13.8. Asia Pacific Retinal Disorder Treatment Market Forecast, by Therapeutic Class

13.8.1. Anti-VEGF Agents

13.8.2. Others (Anti-inflammatory Drugs, etc.)

13.9. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form

13.10. Asia Pacific Retinal Disorder Treatment Market Forecast, by Dosage Form

13.10.1. Gels

13.10.2. Eye Solutions

13.10.3. Capsules & Tablets

13.10.4. Eye Drops

13.10.5. Ointments

13.11. Asia Pacific Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

13.12. Asia Pacific Retinal Disorder Treatment Market Forecast, by Distribution Channel

13.12.1. Hospital Pharmacies

13.12.2. Retail Pharmacies

13.12.3. Online Sales


14. Latin America Retinal Disorder Treatment Market Analysis

14.1. Key Findings

14.2. Latin America Retinal Disorder Treatment Market Overview

14.3. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

14.4. Latin America Retinal Disorder Treatment Market Forecast, by Country/Sub-region

14.4.1. Brazil

14.4.2. Mexico

14.4.3. Rest of Latin America

14.5. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication

14.6. Latin America Retinal Disorder Treatment Market Forecast, by Disease Indication

14.6.1. Macular Degeneration

14.6.1.1. Dry Macular Degeneration

14.6.1.2. Wet Macular Degeneration

14.6.2. Diabetic Retinopathy

14.6.3. Diabetic Macular Edema

14.6.4. Others (Retinal Vein Occlusion, etc.)

14.7. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class

14.8. Latin America Retinal Disorder Treatment Market Forecast, by Therapeutic Class

14.8.1. Anti-VEGF Agents

14.8.2. Others (Anti-inflammatory Drugs, etc.)

14.9. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form

14.10. Latin America Retinal Disorder Treatment Market Forecast, by Dosage Form

14.10.1. Gels

14.10.2. Eye Solutions

14.10.3. Capsules & Tablets

14.10.4. Eye Drops

14.10.5. Ointments

14.11. Latin America Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

14.12. Latin America Retinal Disorder Treatment Market Forecast, by Distribution Channel

14.12.1. Hospital Pharmacies

14.12.2. Retail Pharmacies

14.12.3. Online Sales


15. Middle East & Africa Retinal Disorder Treatment Market Analysis

15.1. Key Findings

15.2. Middle East & Africa Retinal Disorder Treatment Market Overview

15.3. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region

15.4. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Country/Sub-region

15.4.1. GCC Countries

15.4.2. South Africa

15.4.3. Rest of Middle East & Africa

15.5. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Disease Indication

15.6. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Disease Indication

15.6.1. Macular Degeneration

15.6.1.1. Dry Macular Degeneration

15.6.1.2. Wet Macular Degeneration

15.6.2. Diabetic Retinopathy

15.6.3. Diabetic Macular Edema

15.6.4. Others (Retinal Vein Occlusion, etc.)

15.7. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Therapeutic Class

15.8. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Therapeutic Class

15.8.1. Anti-VEGF Agents

15.8.2. Others (Anti-inflammatory Drugs, etc.)

15.9. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Dosage Form

15.10. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Dosage Form

15.10.1. Gels

15.10.2. Eye Solutions

15.10.3. Capsules & Tablets

15.10.4. Eye Drops

15.10.5. Ointments

15.11. Middle East & Africa Retinal Disorder Treatment Market Value Share and Attractiveness Analysis, by Distribution Channel

15.12. Middle East & Africa Retinal Disorder Treatment Market Forecast, by Distribution Channel

15.12.1. Hospital Pharmacies

15.12.2. Retail Pharmacies

15.12.3. Online Sales


16. Competition Analysis

16.1. Global Retinal Disorder Treatment Market Share Analysis, by Company

16.2. Competition Matrix

16.3. Company Profile

16.3.1. Santen Pharmaceutical Co., Ltd.

16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.1.2. Financial Overview

16.3.1.3. Product Portfolio

16.3.1.4. SWOT Analysis

16.3.1.5. Strategic Overview

16.3.2. Regeneron Pharmaceuticals, Inc.

16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.2.2. Financial Overview

16.3.2.3. Product Portfolio

16.3.2.4. SWOT Analysis

16.3.2.5. Strategic Overview

16.3.3. F. Hoffmann-La Roche Ltd.

16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.3.2. Financial Overview

16.3.3.3. Product Portfolio

16.3.3.4. SWOT Analysis

16.3.3.5. Strategic Overview

16.3.4. Pfizer, Inc.

16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.4.2. Financial Overview

16.3.4.3. Product Portfolio

16.3.4.4. SWOT Analysis

16.3.4.5. Strategic Overview

16.3.5. Allergan plc

16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.5.2. Financial Overview

16.3.5.3. Product Portfolio

16.3.5.4. SWOT Analysis

16.3.5.5. Strategic Overview

16.3.6. Shire (Takeda Pharmaceutical Company Limited)

16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.6.2. Financial Overview

16.3.6.3. Product Portfolio

16.3.6.4. SWOT Analysis

16.3.6.5. Strategic Overview

16.3.7. Bayer AG

16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.7.2. Financial Overview

16.3.7.3. Product Portfolio

16.3.7.4. SWOT Analysis

16.3.7.5. Strategic Overview

16.3.8. Graybug Vision, Inc.

16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.8.2. Financial Overview

16.3.8.3. Product Portfolio

16.3.8.4. SWOT Analysis

16.3.8.5. Strategic Overview

16.3.9. Novartis AG

16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.9.2. Financial Overview

16.3.9.3. Product Portfolio

16.3.9.4. SWOT Analysis

16.3.9.5. Strategic Overview

16.3.10. Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)

16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.10.2. Financial Overview

16.3.10.3. Product Portfolio

16.3.10.4. SWOT Analysis

16.3.10.5. Strategic Overview



List of Figures



Figure 01: Global retinal disorder treatment Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Retinal Disorder Treatment Market Value (US$ Mn) and Forecast, 2019–2027

Figure 03: Global Retinal Disorder Treatment Market Value Share (%), by Disease Indication, 2018

Figure 04: Global Retinal Disorder Treatment Market Value Share (%), by Therapeutic Class, 2018

Figure 05: Global Retinal Disorder Treatment Market Value Share (%), by Dosage Form, 2018

Figure 06: Global Retinal Disorder Treatment Market Value Share (%), by Region, 2018

Figure 07: Global Retinal Disorder Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 08: Clinical Trial Analysis by Phase

Figure 09: Clinical Trial Analysis by Status

Figure 10: Clinical Trial Analysis by Completion and Termination Rate

Figure 11: Clinical Trial Analysis by Region

Figure 12: Global Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027

Figure 13: Global Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019–2027

Figure 14: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Macular Degeneration, 2017–2027

Figure 15: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetes Retinopathy, 2017–2027

Figure 16: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diabetic Macular Edema, 2017–2027

Figure 17: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Retinal Vein Occlusion, etc.), 2017–2027

Figure 18: North America Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027

Figure 19: North America Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019–2027

Figure 20: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anti-VEGF Agents, 2017–2027

Figure 21: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Anti-inflammatory Drugs, etc.), 2017–2027

Figure 22: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gels, 2017–2027

Figure 23: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Eye Solutions, 2017–2027

Figure 24: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Capsules & Tablets, 2017–2027

Figure 25: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Eye Drops, 2017–2027

Figure 26: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ointments, 2017–2027

Figure 27: Global Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 28: Global Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 29: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2027

Figure 30: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2027

Figure 31: Global Retinal Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Sales, 2017–2027

Figure 32: Global Retinal Disorder Treatment Market Value Share, by Region, 2018 and 2027

Figure 33: Global Retinal Disorder Treatment Market Attractiveness, by Region, 2019–2027

Figure 34: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 35: North America Retinal Disorder Treatment Market Value Share Analysis, by Country, 2018 and 2027

Figure 36: North America Retinal Disorder Treatment Market Attractiveness, by Country, 2019–2027

Figure 37: North America Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027

Figure 38: North America Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019–2027

Figure 39: North America Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027

Figure 40: North America Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019–2027

Figure 41: North America Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027

Figure 42: North America Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019–2027

Figure 43: North America Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 44: North America Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 45: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 46: Europe Retinal Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 47: Europe Retinal Disorder Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 48: Europe Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027

Figure 49: Europe Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019–2027

Figure 50: Europe Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027

Figure 51: Europe Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019–2027

Figure 52: Europe Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027

Figure 53: Europe Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019–2027

Figure 54: Europe Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 55: Europe Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 56: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 57: Asia Pacific Retinal Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 58: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 59: Asia Pacific Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027

Figure 60: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019–2027

Figure 61: Asia Pacific Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027

Figure 62: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019–2027

Figure 63: Asia Pacific Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027

Figure 64: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019–2027

Figure 65: Asia Pacific Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 66: Asia Pacific Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 67: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 68: Latin America Retinal Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 69: Latin America Retinal Disorder Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 70: Latin America Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027

Figure 71: Latin America Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019–2027

Figure 72: Latin America Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027

Figure 73: Latin America Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019–2027

Figure 74: Latin America Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027

Figure 75: Latin America Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019–2027

Figure 76: Latin America Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 77: Latin America Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019–2027

Figure 78: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 79: Middle East & Africa Retinal Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 80: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 81: Middle East & Africa Retinal Disorder Treatment Market Value Share Analysis, by Disease Indication, 2018 and 2027

Figure 82: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Disease Indication, 2019–2027

Figure 83: Middle East & Africa Retinal Disorder Treatment Market Value Share Analysis, by Therapeutic Class, 2018 and 2027

Figure 84: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Therapeutic Class, 2019–2027

Figure 85: Middle East & Africa Retinal Disorder Treatment Market Value Share, by Dosage Form, 2018 and 2027

Figure 86: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Dosage Form, 2019–2027

Figure 87: Middle East & Africa Retinal Disorder Treatment Market Value Share, by Distribution Channel, 2018 and 2027

Figure 88: Middle East & Africa Retinal Disorder Treatment Market Attractiveness, by Distribution Channel, 2019–2027

 

List of Tables



Table 01: Global Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2027

Table 02: Global Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017–2027

Table 03: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 04: Global Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 05: Global Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 07: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2027

Table 08: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017–2027

Table 09: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 10: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 11: North America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 12: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 13: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2027

Table 14: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017–2027

Table 15: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 16: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 17: Europe Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 18: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 19: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2027

Table 20: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017–2027

Table 21: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 22: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 23: Asia Pacific Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 24: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 25: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2027

Table 26: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017–2027

Table 27: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 28: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 29: Latin America Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 30: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 31: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2027

Table 32: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Macular Degeneration, 2017–2027

Table 33: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Therapeutic Class, 2017–2027

Table 34: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2027

Table 35: Middle East & Africa Retinal Disorder Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027